Variable | Factor Division | n | Hazard Ratio | p |
---|---|---|---|---|
Gender | Male | 49 | 1.436 | 0.4751 |
 | Female |  |  |  |
Neoadjuvant therapy | Not given | 48 | 3.012 | 0.0382 |
 | Given |  |  |  |
Duration of symptoms | ≤ 3 months | 39 | 0.804 | 0.7472 |
 | >3 months |  |  |  |
CEA level | normal | 33 | 1.508 | 0.5916 |
 | elevated |  |  |  |
Tumour location | Right colon | 43 | 1.021 | 0.9586 |
 | Left colon |  |  |  |
 | Rectum |  |  |  |
Histology | adenocarcinoma | 46 | 1.237 | 0.7806 |
 | mucinous |  |  |  |
Differentiation (1) | Well | 46 | 1.716 | 0.2131 |
 | Moderately |  |  |  |
 | Poorly |  |  |  |
Differentiation (2) | Well | 46 | 1.413 | 0.6510 |
 | Non-well |  |  |  |
Differentiation (3) | Poorly | 46 | 0.451 | 0.1475 |
 | Non-poorly |  |  |  |
AJCC stage (1) | I | 46 | 1.835 | 0.0799 |
 | II |  |  |  |
 | III |  |  |  |
 | IV |  |  |  |
AJCC stage (2) | I | 46 | 1.257 | 0.7637 |
 | I1, 111 and 1V |  |  |  |
AJCC stage (3) | 1 and II | 46 | 2.524 | 0.1134 |
 | II,111 and 1V |  |  |  |
AJCC stage (4) | 1,11 and III | 46 | 3.925 | 0.0367 |
 | IV |  |  |  |
Resection Margin | R0 | 46 | 3.684 | 0.0142 |
 | R1 |  |  |  |
Perineural invasion | - | 38 | 2.591 | 0.2304 |
 | + |  |  |  |
Lymphatic invasion | - | 37 | 2.909 | 0.1729 |
 | + |  |  |  |
Vascular invasion | - | 38 | 2.404 | 0.1460 |
 | + |  |  |  |
Tumor margin | Pushing | 13 | 0.817 | 0.8691 |
 | Infiltrating |  |  |  |
Adjuvant therapy (1) | Given | 39 | 3.350 | 0.2471 |
 | Not Given |  |  |  |
Adjuvant therapy (2) | Chemotherapy | 39 | 0.4174 | 0.6576 |